SnagRx vs MedVi: Pricing, support, and compound status compared
SnagRx vs MedVi answers the core choice: if you prioritise the lowest locked-in compounded price across a titration, SnagRx favours cost predictability; if you want a simple online intake with round-the-clock support and a promotional entry price, MedVi may suit you. Early verdict: SnagRx is best for predictable, low annual pricing on compounded GLP-1s; MedVi is best for a first-month promo and 24/7 support.
See SnagRx pricing and plan details
How SnagRx and MedVi differ on price and commitment
SnagRx advertises compounded semaglutide from $69/month and compounded tirzepatide from $119/month as 12-month plan rates; month-to-month equivalents are $99 and $149. MedVi promotes a winter first-month promotional price of $179 with fast, free shipping and notes ongoing standalone months cost $299, with a three-month plan at $649. These are direct-provider claims from each platform.
Check MedVi promotional pricing
Clinician review, support, and process
Both platforms use an online intake and clinician review process. SnagRx states an OpenLoop clinician typically reviews intake within five hours and always within 24 hours; MedVi highlights a simple online process with no clinic visits and 24/7 certified medical support. MedVi emphasizes 24/7 support from certified medical professionals; SnagRx emphasises named clinician network and clinician review speed.
Medication type, pharmacy partners, and regulatory notes
Both SnagRx and MedVi provide compounded semaglutide rather than branded finished products. SnagRx names its US 503A partner pharmacies and its clinician network (OpenLoop Health) and states temperatures controlled next-day shipping. MedVi states medication is filled at a licensed pharmacy and shipped to your door. Both providers include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Support features and guarantees
SnagRx markets outcome-related policies such as a full refund if the prescription is declined and a 6-month weight-loss guarantee with terms. MedVi promotes program inclusion of a physician review, full personalized plan, 1:1 guidance, and a metabolic report for initial program pricing, and cites a promotional first-month offer. MedVi does not publish a weight-loss guarantee in the provided material.
Five-point comparison table
| Criterion | SnagRx | MedVi |
|---|---|---|
| Starting price | From $69/mo for semaglutide on 12-month plan | Promotional first month $179; ongoing months $299 |
| Commitment options | 12-month plan required for $69 rate; month-to-month available at higher rate | No contract for first month; three-month plan available at $649 |
| Medication type | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide only |
| Clinician and support | OpenLoop Health clinician network; clinician review typically within 5 hours | 24/7 certified medical support; simple online intake, no clinic visits |
| Pharmacy and shipping | Names four US 503A partner pharmacies; next-day UPS/FedEx shipping | Medication filled at a licensed pharmacy; fast, free shipping on promo |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Distinctive differences to weigh
1. Price structure and predictability
SnagRx emphasises a price lock: the 12-month plan rate does not change during titration or renewal, which they position as a predictable all-in cost. MedVi offers a low promotional entry price but discloses a materially higher ongoing standalone rate. If long-term flat pricing matters, SnagRx positions that as a differentiator.
2. Support model and availability
MedVi highlights 24/7 certified support as a core feature. SnagRx focuses on rapid clinician review windows and a named clinician network. Your preference for continuous support versus a fast-reviewed clinician pathway will determine which advantage matters more.
3. Medication range and options
SnagRx lists both compounded semaglutide and compounded tirzepatide; MedVi offers compounded semaglutide only. If you want access to tirzepatide through a compounded program, the supplied evidence shows SnagRx supports that option and MedVi does not advertise it.
View SnagRx plans and pharmacy partners
How shipping, refunds, and guarantees compare
SnagRx states next-day temperature-controlled shipping and a full refund if a prescription is declined, plus a 6-month weight-loss guarantee with terms. MedVi states fast, free shipping on promotional pricing and includes program elements like a personalized plan and metabolic report in initial pricing; MedVi does not publish a weight-loss guarantee in the provided material.
Explore MedVi program details and support
Conclusion: choose based on price predictability or initial support
SnagRx is the pick for patients prioritising a low locked-in compounded price over a full titration and named pharmacy and clinician disclosures. MedVi is the pick for patients who value a low promotional first month and 24/7 certified medical support with a simple online intake. Both platforms use compounded semaglutide and note that compounded medications are not FDA-approved. Use the SnagRx vs MedVi comparison above to match the provider attributes to your priorities.
Choose SnagRx if you want predictable, locked-in 12-month pricing from $69/month for compounded semaglutide, named US 503A pharmacies, and rapid clinician review.
Choose MedVi if you want a promotional first-month entry at $179, simple online intake with no clinic visits, and 24/7 certified medical support.